JP2022523056A5 - - Google Patents

Info

Publication number
JP2022523056A5
JP2022523056A5 JP2021543280A JP2021543280A JP2022523056A5 JP 2022523056 A5 JP2022523056 A5 JP 2022523056A5 JP 2021543280 A JP2021543280 A JP 2021543280A JP 2021543280 A JP2021543280 A JP 2021543280A JP 2022523056 A5 JP2022523056 A5 JP 2022523056A5
Authority
JP
Japan
Prior art keywords
phospholipid
liposome composition
polymer
composition according
derivatized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021543280A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022523056A (ja
JP7545393B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/014995 external-priority patent/WO2020154623A1/en
Publication of JP2022523056A publication Critical patent/JP2022523056A/ja
Publication of JP2022523056A5 publication Critical patent/JP2022523056A5/ja
Application granted granted Critical
Publication of JP7545393B2 publication Critical patent/JP7545393B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021543280A 2019-01-24 2020-01-24 誤って折りたたまれたタンパク質を画像化するための機能化リポソーム Active JP7545393B2 (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201962796198P 2019-01-24 2019-01-24
US201962796196P 2019-01-24 2019-01-24
US201962796186P 2019-01-24 2019-01-24
US201962796201P 2019-01-24 2019-01-24
US201962796189P 2019-01-24 2019-01-24
US201962796193P 2019-01-24 2019-01-24
US62/796,189 2019-01-24
US62/796,201 2019-01-24
US62/796,198 2019-01-24
US62/796,186 2019-01-24
US62/796,193 2019-01-24
US62/796,196 2019-01-24
US201962828669P 2019-04-03 2019-04-03
US62/828,669 2019-04-03
PCT/US2020/014995 WO2020154623A1 (en) 2019-01-24 2020-01-24 Functionalized liposomes for imaging misfolded proteins

Publications (3)

Publication Number Publication Date
JP2022523056A JP2022523056A (ja) 2022-04-21
JP2022523056A5 true JP2022523056A5 (enExample) 2023-02-02
JP7545393B2 JP7545393B2 (ja) 2024-09-04

Family

ID=71737450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021543280A Active JP7545393B2 (ja) 2019-01-24 2020-01-24 誤って折りたたまれたタンパク質を画像化するための機能化リポソーム

Country Status (5)

Country Link
US (1) US20200261605A1 (enExample)
EP (1) EP3914230A4 (enExample)
JP (1) JP7545393B2 (enExample)
CN (1) CN113543771A (enExample)
WO (1) WO2020154623A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11614451B2 (en) 2019-07-08 2023-03-28 Alzeca Biosciences, LLC Targeting ligands for tau pathology
JP2025515115A (ja) * 2022-05-06 2025-05-13 テキサス チルドレンズ ホスピタル タウ病態のための標的化リガンド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2350042B1 (en) * 2008-10-17 2015-07-29 Cpl Bcx Pharma Ab Novel thiophene compounds for use in theraphy
WO2010094043A2 (en) * 2009-02-13 2010-08-19 University Of Washington Gadolinium expressed lipid nanoparticles for magnetic resonance imaging
WO2012139080A2 (en) * 2011-04-06 2012-10-11 Board Of Regents Of The University Of Texas System Lipid-based nanoparticles
EP3204051B1 (en) * 2014-10-08 2019-05-29 Texas Children's Hospital Mri imaging of amyloid plaque using liposomes

Similar Documents

Publication Publication Date Title
Yang et al. Gd (iii) chelates for MRI contrast agents: from high relaxivity to “smart”, from blood pool to blood–brain barrier permeable
Kobayashi et al. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores
TW319763B (enExample)
Mohs et al. PEG-g-poly (GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging
PT1931673E (pt) Compostos que compreendem cadeias de aminoálcoois e complexos metálicos para imagiologia médica
JP2017532378A5 (enExample)
JPH05503072A (ja) 診断用nmr映像化の為のヒドロキシ―アリール金属キレート
JP2022523056A5 (enExample)
AU2015330824A1 (en) MRI imaging of amyloid plaque using liposomes
WO2017093336A1 (en) Formulations comprising a combination of mri contrast agents
TW477699B (en) Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes and their use in tumor therapy and interventional radiology
CN102341126A (zh) 用于磁共振成像的钆表现脂质纳米颗粒
IL264363B2 (en) Radioactive phospholipid metal chelates for cancer imaging and therapy
JP7114074B2 (ja) 画像化のためのニトロキシドを含むアミロイド結合剤およびその治療的使用
Beilvert et al. Tyrosine polyethylene glycol (PEG)‐micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque
CN101687803B (zh) 具有全氟化的peg基团的金属螯合物、它们的制备方法及它们的用途
CN101341119B (zh) 具有二亚乙基三胺类金属螯合物结构的高级脂肪酸三酯和酰胺衍生物
JP7545393B2 (ja) 誤って折りたたまれたタンパク質を画像化するための機能化リポソーム
JP7801229B2 (ja) Mri用造影剤としての鉄錯体およびその塩
WO2007147373B1 (en) Pharmaceutical composition for injectional, particularly targeted local administration
AU2007329592A2 (en) Methods of imaging employing chelating agents
CA3031750C (en) Radioactive phospholipid metal chelates for cancer imaging and therapy
EP4676981A2 (en) Contrast agents for collagen and fibrin imaging
IT202200022041A1 (it) Nanostrutture liposomiche caricate con idrogel
CN121985966A (en) Stealth stable sulfur-containing lipid/polyamino acids